BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11191064)

  • 1. HIF-1: using two hands to flip the angiogenic switch.
    Semenza GL
    Cancer Metastasis Rev; 2000; 19(1-2):59-65. PubMed ID: 11191064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors.
    Tsuzuki Y; Fukumura D; Oosthuyse B; Koike C; Carmeliet P; Jain RK
    Cancer Res; 2000 Nov; 60(22):6248-52. PubMed ID: 11103778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced angiogenesis during carcinogenesis.
    Choi KS; Bae MK; Jeong JW; Moon HE; Kim KW
    J Biochem Mol Biol; 2003 Jan; 36(1):120-7. PubMed ID: 12542982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinases and the hypoxia-inducible factor-1, two switches in angiogenesis.
    Mazure NM; Brahimi-Horn MC; Pouysségur J
    Curr Pharm Des; 2003; 9(7):531-41. PubMed ID: 12570801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.
    Fang J; Yan L; Shing Y; Moses MA
    Cancer Res; 2001 Aug; 61(15):5731-5. PubMed ID: 11479208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
    Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
    Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].
    Vandenbunder B
    Bull Cancer; 1998 Oct; 85(10):843-5. PubMed ID: 9835861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer.
    Büchler P; Reber HA; Büchler M; Shrinkante S; Büchler MW; Friess H; Semenza GL; Hines OJ
    Pancreas; 2003 Jan; 26(1):56-64. PubMed ID: 12499918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity.
    Iervolino A; Trisciuoglio D; Ribatti D; Candiloro A; Biroccio A; Zupi G; Del Bufalo D
    FASEB J; 2002 Sep; 16(11):1453-5. PubMed ID: 12205045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.
    Blancher C; Moore JW; Talks KL; Houlbrook S; Harris AL
    Cancer Res; 2000 Dec; 60(24):7106-13. PubMed ID: 11156418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor.
    Karth J; Ferrer FA; Perlman E; Hanrahan C; Simons JW; Gearhart JP; Rodriguez R
    J Pediatr Surg; 2000 Dec; 35(12):1749-53. PubMed ID: 11101729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
    Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
    Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The hypoxia-inducible factor HIF as a new target in cancer research].
    L'Allemain G
    Bull Cancer; 2002 Mar; 89(3):257-60. PubMed ID: 11940464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
    Ravi R; Mookerjee B; Bhujwalla ZM; Sutter CH; Artemov D; Zeng Q; Dillehay LE; Madan A; Semenza GL; Bedi A
    Genes Dev; 2000 Jan; 14(1):34-44. PubMed ID: 10640274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAP kinases and hypoxia in the control of VEGF expression.
    Berra E; Pagès G; Pouysségur J
    Cancer Metastasis Rev; 2000; 19(1-2):139-45. PubMed ID: 11191053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of hypoxia-inducible factor 1 in human cancer.
    Semenza GL
    Intern Med; 2002 Feb; 41(2):79-83. PubMed ID: 11868612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
    Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.